Myeloid Therapeutics

formerly CREATE Medicines

Create Medicines | In Vivo Immune Programming with RNA-CAR Therapies

Cambridge, United States · Founded 2021 · $257.0M raised

Employees
11–50
Founded
2021
Business Model
B2B
Total Funding
$257.0M
Last Round
$122.0M Series BMay 2026
Rounds
4

About

Myeloid Therapeutics (rebranded as CREATE Medicines in October 2025) was a clinical-stage biotech pioneering in vivo immune programming using mRNA-LNP technology. Its platform engineers T cells, NK cells, and myeloid cells directly inside the body, enabling repeat-dose CAR therapies without ex vivo manufacturing.

Summary

Myeloid Therapeutics is a Biotech company based in Cambridge, United States, founded in 2021. It has raised $257.0M in total across 4 rounds, most recently a $122.0M Series B round in May 2026. Investors include Newpath Management, ARCH Venture Partners and Hatteras Venture Partners.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Sign up to view the funding chart

Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.

Series BSeries BMay 2026
$122.0M

Sign up to see all 4 rounds

Seed through Series B — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Myeloid Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/myeloid-therapeutics"><img src="https://indexed.vc/api/badge/company/myeloid-therapeutics" alt="Myeloid Therapeutics on Indexed.vc" width="260" height="76" /></a>